Aerodrug

EVENTS - First semester 2012

sandrine — 2012-02-06T14:23:58Z

AERODRUG will be present at The 35th European Cystic Fibrosis Conference (ECFS), 6 - 9 June, in DUBLIN (Ireland). The ERS/ISIAN 2012 conference, 17-21 June in TOULOUSE (France): 24th Congress of European Rhinology Society (ERS) & the 31th International Symposium of Infections and Allergy of the Nose (ISIAN), You will be welcome on the DTF exhibitor stand (...) - News

JAN, 2012 - A licence for a new INHALATION CHAMBER

sandrine — 2012-02-06T10:12:39Z

The french company PROTEC'SOM is specialized in development and manufacturing of medical devices dedicated to asthma and allergy. PROTEC'SOM has signed an exclusive licence with AERODRUG for a new INHALATION CHAMBER in development. This new chamber will be presented at the 11th International Congress on Pediatric Pneumology (CIPP)- in July 2012 (Bangkok, Thailand) and at the American Thoracy Society international conference (ATS) - in May 2012 (San Francisco, California). (...) - News

EASYNOSE

sandrine — 2012-02-03T14:37:50Z

Specially designed for sino-nasal treatment. The EASYNOSE is a new nebulizer device developed for nasal delivery. Simply innovative, this new nasal nebulization system (patent pending) minimizes penetration of aerosol in the pulmonary area, and increases the nasal and sino-nasal aerosol deposition. Really compliant nebulization system No patient participation In vivo study Scintigraphic evaluation of the EASYNOSE nebulizer (B) in healthy volunteers with DTPA-Tc99m aerosol, in (...) - Development

IDEHALER®-POCKET

sandrine — 2012-02-02T14:17:35Z

A VIRTUAL VALVE HOLDING CHAMBER Based on dynamic fluid properties, an innovative new vertical holding chamber has been developed for a mesh nebulizer. The IDEHALER®-POCKET offers a virtual valve nebulization system. In terms of performance, the IDEHALER®-POCKET allows to: increase the inhalable ratio - up to 77%, deliver a 4µm particle size aerosol. The IDEHALER®-POCKET offers the advantage to be very small and portable, easy to use. Scientific communication !NEW! Feasibility (...) - Development

Sept. 9th, 2011. Success of the clinical study with the Idehaler®Pocket.

sandrine — 2011-09-19T12:09:41Z

The Idehaler®Pocket in evaluation for an antibiotic nebulization. Aerodrug announces the success of the clinical study evaluating the Idehaler®Pocket/Aeroneb®go device for the nebulization of an antibiotic in CF patients. The Idehaler®Pocket is a vertical holding chamber, portable and easy to use, which allows the production of inhalable drug ratio up to 77%. The Idehaler®Pocket has already proved its efficacy in vitro and in vivo. It is currently selected for several pulmonary clinical (...) - News

Sept. 14th, 2011. SFORL and DDL conferences.

sandrine — 2011-09-19T12:08:09Z

Aerodrug announces its presence in Paris (France) for the conference of the Ear-Nose-Throat French Society (SFORL) and in Edinburgh (Scotland, UK) for the Drug Delivery to the Lungs (DDL) conference. We will be pleased to welcome you: On the 15th -17th October for the 118th SFORL congress, on our DTF medical stand n° 33. On the 7th - 9th December at the 22th DDL conference on our DTF medical stand which will be held at the Edinburgh International Conference Centre. At this occasion, the (...) - News

April 29th, 2011 - The Idehaler®Pocket selected for clinical study

sandrine — 2011-09-19T12:06:37Z

April 29th, 2011 The IDEHALER®POCKET (in association with the AERONEB®Go) was chosen by the canadian multicenter clinical trial as the nebulization system for magnesium sulfate (MgSO4) in pediatric asthmatic patients. LINKS Linked article : Coates AL., Leung K., Vecellio L., Schuh S. Respir Care. 2011 Mar;56(3):314-8. Testing of nebulizers for delivering magnesium sulfate to pediatric asthma patients in the emergency department. Pubmed abstract (...) - News

May 16th , 2011. A nasal clinical trial with the Easynose.

sandrine — 2011-09-19T12:06:17Z

May 16th, 2011 The Easynose, the new nebulization system for nasal delivery has been selected for a phase III clinical study in patients with chronic rhinosinusitis (CRS patients). The trial is currently in recruitment. - News

April 29th, 2011 - ECFS and ISAM conference 2011

sandrine — 2011-04-29T14:10:12Z

Aerodrug announces its presence this year in Hamburg (Germany) for the European Cystic Fibrosis Society (ECFS) conference and in Rotterdam (the Netherlands) for the International Society of Aerosols Medicine (ISAM) congress. We will be pleased to welcome you: The 8-11th June for the 34th ECFS Conference, on a common exhibition stand ALAXIA/DTF medical The 18-22th June for the 18th ISAM Congress, on our stand DTF medical (stand (...) - News

February 28th, 2011- Financial support to develop a new drug device

sandrine — 2011-02-28T09:15:07Z

February 28th, 2011 Aerodrug has obtained a grant to work in collaboration with the French army DGA. The project is to develop a new drug device combination to target peripheral lung. For this occasion, a PhD engineer has joined Aerodrug for three years to work in close connection with the French army and the Inserm U618 team. - News